Oral Abstract Session:
33a. PIDS Featured Oral Abstracts
Thursday, October 27, 2016: 10:30 AM-11:00 AM
Room: 391-392

Learning Objectives:


Tracks: Pediatric ID, Investigative ID

Moderator:  Janet Gilsdorf, MD, FIDSA, FPIDS, University of Michigan Medical Center

10:30 AM
Impact of the Revised Guidelines for Respiratory Syncytial Virus (RSV) Prophylaxis: Morbidity Persists AfterTwo Seasons!
Phillip Wozniak, BA ; Pablo J. Sanchez, MD, FIDSA, FPIDS ; Bavani Rajah, BS ; Patricia Gruber, RN ; Jacqueline Magers, PharmD ; Octavio Ramilo, MD, FPIDS ; Asuncion Mejias, MD, PhD
10:45 AM
Safety, Tolerability and Pharmacokinetics (PK) of Intravenous Zanamivir (IVZ) Treatment in Hospitalized Pediatric and Adolescent Patients with Influenza: A Phase II Open-Label, Multicenter, Single- Arm Study
Jeffrey Blumer, MD, PhD ; John S. Bradley, MD, FIDSA, FPIDS ; Jose R. Romero, MD ; Marian Michaels, MD, MPH ; David W. Kimberlin, MD, FIDSA, FPIDS ; Go Yamamoto, MD ; Grace Roberts, MS ; Mohammad Hossain, PhD ; Denise Shortino, MS ; Phillip Yates, PhD ; Bryan Adams, PhD ; Amanda Peppercorn, MD

CME Credits: No CME credit is offered for this session.

ACPE Credits:

ACPE Number:

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.